Unbiased Analysis of Today's Healthcare Issues

Archive for July, 2015

Friday Links

Being transgender and finding a doctor. Do you accurately perceive your risk of death? Performance-based financing in Cambodia. The cost of obesity in China. 5.25 seconds.

Read the rest of this entry »

ACC/AHA Statement on Measuring Treatment Value

The conventional premise governing performance measures and guideline recommendation…is that all healthcare professionals should act in the best interests of their patients without regard to costs. However, as the cost of medical care has increased, specialty societies are increasing considering the cost of care when selecting treatments. For instance, A recent survey reported that slightly […]

Read the rest of this entry »

Is Medicare no longer a budget buster?

Not entirely, but the 2015 Medicare Trustees report is certainly more optimistic than in the past. Brookings reports: The Trustees have dramatically lowered their projections of long-run Medicare expenditure growth. In 2009, for example, the Trustees projected that Medicare spending would reach 11.2 percent of GDP by 2080—compared with just 6 percent in this year’s […]

Read the rest of this entry »

Does your employer cover transgender benefits?

It may be more likely than you think. The Health Business Blog (via Business Insurance) notes that: …the Office of Personnel Management recently required Federal Employee Benefit Plan providers to cover transition-related care…About half of large employers offer transgender-related surgical coverage compared with 5 percent in 2007, according to a National Business Group on Health survey. […]

Read the rest of this entry »

Friday Links

Paying for primary care. Is marijuana ‘medical’? Why rent control is bad. Minimum wage. Health insurance and cable.

Read the rest of this entry »

Basket vs. Umbrella clinical trials

How do you determine if a drug is effective?  Typically, biostaticians rely on a randomized control trial where half the patients receive the treatment of interest and the remaining half receive either a placebo or the current standard of care depending on the trial design. Recent advances in cancer, however, call for more sophisticated designs.  Some cancer treatments are only […]

Read the rest of this entry »

International Reference Pricing

What is international reference pricing (IRP)? IRP is system whereby a country states that they will pay no more than the price paid by another country or a basket of countries. In theory, countries could also regulate drug prices by saying that they would not pay more than X% of country A’s price or X% […]

Read the rest of this entry »

Quotation of the Day

The human mind is generally far more eater to praise and dispraise than to describe and define.  It wants to make every distinction of value; hence those fatal critics who can never point out the differing quality of two poets without putting them in an order of preference as if they were candidates for a […]

Read the rest of this entry »

Half a trillion dollars

Clearly, the care family members provide for sick relatives add significant value to the life of the infirm. Many non-economists may consider the cost of this care as “free” because family members typically are not paid for this services.  However, nothing could be further from the truth.  If family members were not caring for their […]

Read the rest of this entry »

Links

How to push a wheelchair. Rocket failures. How to Win Friends and Influence Doctors. No more snacks? Oliver on stadiums

Read the rest of this entry »